Article Information
History
- April 10, 2022.
Article Versions
- You are currently viewing Version 1 of this article (April 10, 2022 - 20:42).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available for use under a CC0 license.
Author Information
- 1TyrolPath Obrist Brunhuber GmbH, Zams, Austria
- 2National Institute of Diabetes, Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA
- 3Clinical Core, National Institute of Diabetes, Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA
- 4Departments of Oncology & Medicine, Georgetown University, Washington, DC, USA
- ↵*Corresponding authors: Lothar Hennighausen, lotharh{at}nih.gov